Average Insider

Where insiders trade, we follow

$CATX
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Healthcare
Sector
Medical - Devices
Industry
Johan Spoor
CEO
138
Employees
$0.84
Current Price
$211.08M
Market Cap
52W Low$0.78
Current$0.841.2% above low, 98.8% below high
52W High$6.16

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys23$72,487.6088,000All Buys
Sells00--
2 weeksBuys23$72,487.6088,000All Buys
Sells00--
1 monthBuys23$72,487.6088,000All Buys
Sells00--
2 monthsBuys23$72,487.6088,000All Buys
Sells00--
3 monthsBuys23$72,487.6088,0001:22.38
Sells27$1,622,534.32517,889
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 11, 2026
Puhlmann Markus
Chief Medical Officer
Purchase6,000$0.83$4,980.00View Details
Nov 12, 2026
Puhlmann Markus
Chief Medical Officer
Purchase35,000$0.84$29,564.50View Details
Nov 11, 2026
Spoor Johan M.
Director
Purchase47,000$0.81$37,943.10View Details
Sep 3, 2026
Lantheus Alpha Therapy, LLC
10% Owner
Sale80,783$3.11$250,895.84View Details
Sep 4, 2026
Lantheus Alpha Therapy, LLC
10% Owner
Sale167,149$3.15$526,051.33View Details
Sep 2, 2026
Lantheus Alpha Therapy, LLC
10% Owner
Sale42,129$3.11$131,219.20View Details
Sep 1, 2026
Lantheus Alpha Therapy, LLC
10% Owner
Sale35,769$3.12$111,574.24View Details
Aug 31, 2026
Lantheus Alpha Therapy, LLC
10% Owner
Sale78,145$3.14$245,609.73View Details
Sep 1, 2026
Lantheus Holdings, Inc.
10% Owner
Sale35,769$3.12$111,574.24View Details
Aug 31, 2026
Lantheus Holdings, Inc.
10% Owner
Sale78,145$3.14$245,609.73View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 9, 2026
EPS
Estimated-$0.24
Actual-$0.27
Miss
Revenue
Estimated$56.50K
Actual$20.00K
Miss
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12